Article
Federal Circuit Holds Marketing Of Generic Bioequivalent Can Satisfy Induced Infringement
The U.S. Court of Appeals for the Federal Circuit held that a generic drug manufacturer's marketing of a generic bioequivalent with knowledge and intent ...
Pearl Cohen Zedek Latzer Baratz
